U.S. Bio-Detection Homeland Security & Defense Technology & Market Forecast – 2010-2014

Description

Publication: Q1 2009, Pages: 222, Tables & Figures: 146

$1.6 Billion Over the Next Four Years.

U.S. Bio-Detection Homeland Security & Defense Technology & Market Forecast - 2010-2014

The bio-detection markets present some of the fastest growing and vibrant markets in the homeland security industry. The Obama administration is committed to accelerating the pace of bio-terror mitigation spending. In February 2009, the Congress passed a bill that included more than $1.7 billion in additional funding for bio-security and bio-health, and R&D.

This report describes the technologies and markets dedicated to using biological detectors for either constant, automatic, standoff surveillance of an indoor facility (e.g., mall, postal distribution center), an outdoor environment, or manual usage by 1st responders to check whether or not suspect traces consist of bio-terror agents. Such systems, in the context of homeland security, are mainly designed to mitigate the effects of biological terrorism.

HSRC’s team of scientists and industry executives meticulously researched and analyzed each of the 4 modalities of bio-detection:
  • Outdoor Automatic Standoff-Detectors (e.g., Project BioWatch)
  • Indoor Automatic Standoff-Detectors
  • Emergency Responder Biological Mobile Labs
  • Emergency Responder Biological Hand-Held Detectors
For each modality, the research provides a detailed analysis and forecast for three generations of technologies, providing a look at the twelve market segments that will make up this industry for the next five years. For each of the modalities, the research provides the following:
  • Present & Next Generation Technologies – present technologies analysis and an in depth analysis of bio-detection candidates of next generation technologies
  • Current and upcoming business opportunities –18 specific business opportunities outlined and analyzed
  • 2010-2014 Market Forecasts– various and detailed forecasts of annual sales in units and dollars, for the next fice years
  • 2010-2014 Service and Upgrade Business – five year forecasts of the service and equipment installation and upgrade business, which are the main source of gross margin for this industry
Table of Contents Table of Contents
Download TOC as PDF
1. Scope
1.1. Definition of Biological Terrorism
1.2. Scope
1.2.1. Bio Weapon Types
1.3. Basic Assumptions
1.3.1. General
1.3.2. Why Conduct Constant Surveillance for Biological Warfare Threats?
1.3.3. Possible Scenario Analysis
1.4. Methodology
1.4.1. Research Methods
1.4.2. Report Structure
1.5. Who is This Report For?
2. Executive Summary
2.1. Main Conclusions
2.2. The Threat of Bioterrorism
2.3. How Real Is The Bioterrorism Threat?
2.4. Defending Against Bioterrorism
2.4.1. Project BioWatch
2.4.2. Project BioSense
2.4.3. Project BioShield
2.5. Bio-Detection – The Industry
2.6. Bio-Detection Market Forecast – 2010-2014
2.6.1. Total Bio-Detection Systems and Service Market Forecast – 2010-2014
2.6.2. Bio-Detection Systems & Service Market Forecast by Modality – 2010-2014
2.6.3. Bio-Detection Market Forecast by Technology Generation – 2010-2014
2.7. Bio-Detection – Next Generation Business Opportunities
2.8. Bio-Detection – Technologies Outlook
3. Bio-Detection Market – Drivers
4. Bio-Detection Market – Inhibitors
5. The Obama Administration Bio Terror Mitigation Strategy
5.1. Bio-Defense Funding
5.1.1. DHHS Bio-Defense Missions and Funding
5.1.2. DHS Bio-Defense Missions and Funding
5.1.3. DOD Bio-Defense Missions and Funding
5.1.4. DOA Bio-Defense Missions and Funding
5.1.5. EPA Bio-Defense Missions and Funding
5.1.6. Other Bio-Defense Missions and Funding
5.2. The Obama Administration Bio-Defense Strategy
6. Bio-Detection – Technologies Overview
6.1. Bio-Detection Technology Challenges
6.1.1. Sampling the Environment
6.2. The Bio-Detection Process
6.2.1. Bio-Detectors in a Multitude of Ambient Settings
6.2.2. Bio-Detection Triggering
6.2.3. Collection of Particles
6.2.4. Bio-Particle Detectors
6.2.5. Bio-Agent Identification
7. Bio-Detection Technological Challenges
7.1. Challenge 1 – Detection of Small Particle Concentration
7.2. Challenge 2 – Eliminating Bio Background
7.3. Challenge 3 – Expensive Reagents
7.4. Challenge 4 – Expensive Equipment Maintenance
7.5. Challenge 5 – Adapting Equipment to Changing Environments
7.6. Challenge 6 – Dealing With Emerging Threats
8. Bio Detection Technologies Review & Outlook – 2010-2014
8.1. Bio-Detection – Core Technologies Comparison
8.2. Collector/Concentrator Core Technologies
8.3. Cyclone Collectors
8.4. Variable Particle-Size Impactor
8.5. Virtual Impactors
8.6. Impingers
8.7. Reagentless Trigger Core Technologies
8.7.1. Flow Cytometry
8.7.2. Particle Sizing
8.7.3. Gas Chromatography
8.7.4. Trigger Technologies – Drivers
8.7.5. Trigger Technologies – Inhibitors
8.8. DNA Based Diagnostic Core Technologies
8.8.1. Overview of DNA-Based Detection
8.8.2. Polymerase Chain Reaction (PCR)
8.8.3. DNA / RNA Microarrays
8.8.4. DNA Technology Drivers
8.8.5. DNA Technology Inhibitors
8.9. Antibody-Antigen Diagnostic Core Technologies
8.9.1. Overview of Antibody-Antigen Reaction
8.9.2. Hand-Held Immuno-Chromatographic Assays (HHA)
8.9.3. Magnetic Microbead-Base Assays
8.9.4. Microfluidic Devices – "Lab on a Chip"
8.9.5. Fluorescence Imaging
8.9.6. Electrochemical-Luminescence (ECL)
8.9.7. Antibody/Antigen Technology – Drivers
8.9.8. Antibody/Antigen Technology – Inhibitors
8.1. Signal Analysis Algorithms
8.10.1. Clustering / Classifier Algorithms
8.10.2. Image Analysis Algorithms
8.10.3. Decision Algorithms
8.10.4. Algorithm Drivers
8.10.5. Algorithm Inhibitors
8.11. Rapid Microbiological Technologies
9. Biological Detection – Overview by Application
9.1.1. Application 1 – Emergency Responder Hand-Held Detectors
9.1.2. Application 2 – Emergency Responder Mobile Labs
9.1.3. Application 3 – Indoor Standoff Detectors
9.1.4. Application 4 – Outdoor Standoff Detectors
10. U.S. Bio-Detection Systems Market Outlook – 2010-2014
10.1. Scope, Assumptions and Overview
10.1.1. Scope
10.2. Bio-Detection Systems Revenue Sales Forecast – 2010-2014
10.2.1. Bio-Detection Systems Revenue Sales by Generation Forecast – 2010-2014
10.2.2. Bio-Detection Systems Sales by Modality Forecast – 2010-2014
10.3. Bio-Detection Systems Quantity Sales Forecast – 2010-2014
10.3.1. Bio-Detection Systems Quantity Sales by Generation Forecast – 2010-2014
10.3.2. Bio-Detection Systems Quantity Sales by Modality Forecast – 2010-2014
10.4. Bio-Detection Systems Installed Base Forecast – 2010-2014
10.4.1. Bio-Detection Systems Installed Base by Generation Forecast – 2010-2014
10.4.2. Bio-Detection Systems Installed Base by Modality Forecast – 2010-2014
10.5. Bio-Detection Outdoor Standoff-Detection Systems – Market Forecast – 2010-2014
10.5.1. Outdoor Standoff Detection Systems Revenue Sales Outlook – 2010-2014
10.5.2. Outdoor Standoff Detection Systems Quantity Sales Outlook – 2010-2014
10.5.3. Outdoor Standoff Detection Systems Installed Base Outlook – 2010-2014
10.6. Bio-Detection Indoor Systems Standoff-Detection Market Forecast – 2010-2014
10.6.1. Indoor Standoff Systems Detection Sales Outlook – 2010-2014
10.6.2. Indoor Standoff Detection Systems Unit Sales Outlook – 2010-2014
10.6.3. Indoor Standoff Detection Systems Installed Base – 2010-2014
10.7. Bio-Detection – Point-Detection (Detect-to-Treat) Systems - Installed Base Forecast – 2010-2014
10.7.1. Point-Detection Summary Overview
10.8. Bio-Detection First Responder Hand-Held Detection Systems Market Forecast – 2010-2014
10.8.1. First Responder Hand-Held Detection Systems Sales Outlook – 2010-2014
10.8.2. First Responder Hand-Held Detection Systems Quantity Sales Outlook – 2010-2014
10.8.3. First Responder Hand-Held Detection Systems Installed Base – 2010-2014
10.9. Bio-Detection First Responder Mobile Labs Detection Systems Market Forecast – 2010-2014
10.9.1. First Responder Mobile Labs Sales Outlook – 2010-2014
10.9.2. First Responder Mobile Labs Quantity Sales Outlook – 2010-2014
10.9.3. First Responder Mobile Labs Installed Base – 2010-2014
11. Bio-Detection Service Business Outlook – 2010-2014
11.1. Bio-Detection Service & Upgrade Business Forecast by Modality – 2010-2014
11.2. Bio-Detection Service Business Forecast by Technology Generation – 2010-2014
12. Bio-Detection Business Opportunities – 2010-2014
12.1. Historical Perspective: A Market Waiting for Transition
12.1.1. The Current and Future HLS Bio-Defense Strategy for Detection
12.1.2. Factors Affecting Biological Detectors Deployment and Technologies – 2010-2014
12.1.3. Biological Detection Technology Timeline – 1992-2014
12.2. Business Opportunities for Next Generation HLS Bio-Detection Systems
12.2.1. Business Opportunity 1 – Emerging Threats
12.2.2. Business Opportunity 2 – Human Sentinel Surveillance System
12.2.3. Business Opportunity 3 – Animal Sentinel Surveillance System
12.2.4. Business Opportunity 4 – Biological IC3 – Biological Threat Assessment Intelligence Command, Control, and Communication Infrastructure
12.2.5. Business Opportunity 5 – Reducing False Alarms – Lesser False Positives and False Negatives
12.2.6. Business Opportunity 6 – Reducing Cost – Minimizing Use of Non-Reusable Reagents
12.3. Outdoor Standoff Biological Detectors
12.3.1. Business Opportunity 7 – Bioagent Autonomous Networked Detectors (BAND)
12.3.2. Business Opportunity 8 – Rapid Automated Biological Identification System (RABIS)
12.3.3. Business Opportunity 9 – First Responder Portable Hand-Held Detector
12.3.4. Business Opportunity 10 – First Responder Mobile Biological Detection Station
12.3.5. Business Opportunity 11 – Regional Automatic Detector – Outdoor Standoff Detectors
12.3.6. Business Opportunity 12 – Networked Automatic Detector – Indoor Standoff Detectors
12.3.7. Business Opportunity 13 – External Spread of Bioagent Detection
12.3.8. Business Opportunity 14 – Internal Spread of Bioagent
12.4. Other Bio-Detection Technologies – Business Opportunities
12.4.1. Business Opportunity 15 – "Lab on a Chip" – Miniature Detection Devices
12.4.2. Business Opportunity 16 – Reagentless Specific Detection Assays
12.4.3. Business Opportunity 17 – Laser Induced Breakdown Spectroscopy (LIBS)
12.4.4. Business Opportunity 18 – Raman Spectroscopy-based Reagentless Detection
12.5. Future Technologies and Systems
13. Bio-Defense Federal R&D Funding Opportunities – 2010-2014
13.1. Summary & Outlook
13.2. Bio-Defense Federal R&D Funding Forecast – 2010-2014
13.2.1. DHS Biosecurity R&D
13.2.2. DOD Bio-Security R&D
13.2.3. DHHS Biosecurity R&D
13.2.4. Other Agencies Biosecurity R&D
13.3. HLS-HLD Bio-Detection R&D Funding – Drivers
13.4. HLS-HLD Bio-Detection R&D Funding Opportunities – Inhibitors
13.5. DHS – Biological Detection HLS Technologies R&D Programs
13.5.1. Surveillance and Detection R&D
13.5.2. Rapid Development for Sensors for Novel Threat Agents
13.5.3. Cross Correlation of Environmental Biological Sensors and Human Illness
13.5.4. Facility Airborne Biological Toxin Alarm System (FABTAS)
13.5.5. Field-Deployable Detection Technology for the Identification of Biological Toxins
13.5.6. Forensics
13.6. DARPA (DOD) – Biological Detection HLS Technologies R&D Programs
13.6.1. Handheld Isothermal Silver Standard Sensor (HISSS)
13.6.2. Triangulation Identification for Genetic Evaluation of Biological Risk (TIGER)
13.6.3. Spectral Sensing of Bio-Aerosols (SSBA)
13.6.4. Threat Agent Cloud Tactical Intercept Countermeasure (TACTIC)
13.6.5. Immune Buildings
13.7. CBDP (DOD) – Biological Detection HLS Technologies R&D Programs
13.7.1. Project CB1 – Biological Defense (Basic Research) – Detection
13.7.2. Project CB2 – Biological Defense (Applied Research) – Detection
13.7.3. Project CB3 – Biological Defense (ATD) – Detection
13.7.4. Project CA5 Contamination Avoidance (SDD)
13.8. TSWG – Biological Detection HLS Technologies R&D Programs
13.8.1. Real-Time Biological Aerosol Detection
14. Bio-Detection Pricing Outlook – 2010-2014
15. Bio-Detection – Economic Considerations
15.1. Overview
15.2. Economical Analysis – Assumptions
15.2.1. Bio-Detection – Economic Analysis
15.2.2. Cost of Equipment Ownership
15.2.3. Cost of Personnel/Year
15.2.4. Cost of Test
16. Bio-Detection – Personnel Considerations
16.1. Background – Personnel
16.2. Personnel Training
17. Bio-Detection – Vendors and Products
17.1. Bio Detection Samplers and Products
17.2. Bio Detection Kits – Vendors and Products
17.3. Bio Detection Screening Devices – Vendors and Products
18. Appendix A: The Threat of Bioterror
18.1. Use of Bioweapons – Historical Perspective
18.2. Biological Terror – Bacterial Agents
18.2.1. Anthrax
18.2.2. Cholera
18.2.3. Plague
18.2.4. Tularemia
18.3. Biological Terror – Viral Agents
18.3.1. Smallpox
18.3.2. Hemorrhagic Fever Viruses
18.3.3. Venezuelan Equine Encephalitis
18.4. Biological Terror – Rickettsiae Agents
18.4.1. Q Fever
18.4.2. Typhus
18.5. Biological Terror – Toxins
18.5.1. Botulinum Toxin
18.5.2. Ricin
18.5.3. Saxitoxin
18.5.4.  Staphylococcal Enterotoxin B (SEB)
19. Appendix B: Bio-Detection – Patent Review
19.1. Scope
19.2. Bio-Detection Patents
20. Appendix C: Legal Issues
20.1. International / European Legislation / Agreements
20.1.1. The Biological and Toxin Weapons Convention (BTWC) 1972
20.2. U.S. Bioterrorism Legislation
Figures/Tables Tables
Table 1 HLS & Defense Bio-Detection Systems and Service Market [$M] 2008 & 2014 – by Product Classification
Table 2 Federal HLS-HLD Bio-Defense Funding [$Million] – FY2001-FY2009
Table 3 U.S. HLS Bio-Detection Systems and Service Market Forecast [$ Million] – 2010-2014
Table 4 U.S. HLS Bio-Detection Systems & Service (S&S) Market Forecast by Expenditure Share [%] – 2010-2014
Table 5 U.S. HLS Bio-Detection Systems & Service Market Forecast by Portability [$ Million] – 2010-2014
Table 6 U.S. HLS Bio-Detection Systems & Service Market Forecast by Modality Share [%] – 2010-2014
Table 7 Bio-Detection Systems Sales by Generation [$ Million] – 2010-2014
Table 8 Bio-Detection Systems Sales by Generation [%] – 2010-2014
Table 9 Bio-Detection Service and Upgrade Business Forecast by Technology Generation [$ Million] – 2010-2014
Table 10 Bio-Detection Service and Upgrade Business Forecast by Technology Generation Share [%] – 2008-2014
Table 11 U.S. Federal HLS-HLD Bio-Defense Funding [$ Millions], by Agency – FY2001-FY2009
Table 12 Comparison of Attributes of Bio-Detection Technologies
Table 13 Bio-Detection Systems Sales by Generation [$ Million] – 2010-2014
Table 14 Bio-Detection Systems Sales by Generation Share [%] – 2010-2014
Table 15 Bio-Detection Consolidated Sales by Modality [$M] – 2010-2014
Table 16 Bio-Detection Systems Sales by Modality Share [%] – 2010-2014
Table 17 Bio-Detection Systems Quantity Sales by Generation [Units] – 2010-2014
Table 18 Bio-Detection Systems Quantity Sales by Generation Share [%] – 2010-2014
Table 19 Bio-Detection Systems Quantity Sales by Modality [Units] – 2010-2014
Table 20 Bio-Detection Systems Quantity Sales by Modality Share [%] – 2010-2014
Table 21 Bio-Detection Systems Installed Base by Generation [Units] – 2010-2014
Table 22 Bio-Detection Systems Installed Base Share [%] by Generation – 2010-2014
Table 23 Bio-Detection Systems Installed Base by Modality [Units] – 2010-2014
Table 24 Bio-Detection Systems Installed Base by Modality Share [%] – 2010-2014
Table 25 Outdoor Standoff Detectors Systems Sales by Generation [$ Million] – 2010-2014
Table 26 Outdoor Standoff Detectors Systems Sales by Generation Share [%] – 2010-2014
Table 27 Outdoor Standoff Detectors Systems Sales [Units] – 2010-2014
Table 28 Outdoor Standoff Detectors Systems Sales Share [%] – 2010-2014
Table 29 Outdoor Standoff-Detectors Systems Installed Base [Units] – 2010-2014
Table 30 Outdoor Standoff-Detectors Systems Installed Base Units Share [%] – 2010-2014
Table 31 Indoor Standoff Detectors Systems Sales by Generation [$M] – 2010-2014
Table 32 Indoor Standoff Detectors Systems Sales by Generation Share [%] – 2010-2014
Table 33 Indoor Standoff Detectors Systems Sales by Generation [Units] – 2010-2014 CAGR
Table 34 Indoor Standoff Detectors Systems Sales by Generation Share [%] – 2010-2014
Table 35 Indoor Standoff-Detectors Systems Installed Base by Generation [Units] – 2010-2014
Table 36 Indoor Standoff-Detectors Systems Installed Base by Generation Share [%] – 2010-2014
Table 37 Point-Detectors Installed Base Systems by Modality [Thousand of Units] – 2010-2014
Table 38 First Responder Hand-Held Detection Systems Sales [$M] by Generation – 2010-2014
Table 39 First Responder Hand-Held Detection Systems Sales by Generation Share [%] – 2010-2014
Table 40 First Responder Hand-Held Detection Systems Sales [Units] by Generation – 2010-2014
Table 41 First Responder Hand-Held Detection Systems Sales by Generation Share [%] – 2010-2014
Table 42 First Responder Hand-Held Detection Systems Installed Base by Generation [Units] – 2010-2014
Table 43 First Responder Hand-Held Detection Systems Installed Base by Generation Share [%] – 2010-2014
Table 44 First Responder Mobile Labs Sales by Generation [$M] – 2010-2014
Table 45 First Responder Mobile Labs Sales by Generation Share [%] – 2010-2014
Table 46 First Responder Mobile Labs Sales by Generation [Units] – 2010-2014
Table 47 First Responder Mobile Labs Unit Sales by Generation Share [%] – 2010-2014
Table 48 First Responder Mobile Labs Installed Base by Generation [Units] – 2010-2014
Table 49 First Responder Mobile Labs Units Installed Base by Generation Share [%] – 2010-2014
Table 50 Bio-Detection Service & Upgrade Business Forecast by Modality [$M] – 2010-2014
Table 51 Bio-Detection Service & Upgrade Business Forecast by Modality Share [%] – 2010-2014
Table 52 Bio-Detection – Service Business Forecast by Technology Generation [$M] – 2010-2014
Table 53 Bio-Detection Service Business Forecast by Technology Generation Share [%] – 2010-2014
Table 54 Bio-Defense R&D Federal Funding by Agency [$ Million] – 2010-2014
Table 55 Bio Detection Samplers – Vendors and Products
Table 56 Bio Detection Kits – Vendors and Products
Table 57  Bio-Detection Screening Devices – Vendors and Products

Figures
Figure 1 Types of Biological Detectors
Figure 2 HLS & Defense Bio-Detection Systems and Service Market [$M] 2008 & 2014 – by Product Classification
Figure 3 Bio-Detection Strategy – Three Pillars Diagram
Figure 4 U.S. Government HLS-HLD Bio-Defense Funding [$ Million] – FY2001-FY2009
Figure 5 U.S. HLS Bio-Detection Systems & Service Market Forecast [$ Million] – 2010-2014
Figure 6 U.S. HLS Bio-Detection Systems & Service Market Share [%] – 2008, 2011 & 2014
Figure 7 U.S. HLS Bio-Detection Systems & Service Market Forecast by Modality [$ Million] – 2010-2014
Figure 8 U.S. HLS Bio-Detection Systems & Service Market Forecast by Modality Share [%] – 2008, 2011 & 2014
Figure 9 Bio-Detection Systems Sales by Generation [$ Million] – 2010-2014
Figure 10 Bio-Detection Service Business Forecast by Technology Generation [$ Million] – 2010-2014
Figure 11 Cumulative 2001-2009 Bio-Defense Funding [$Million], by Agency
Figure 12 Bio-Defense Funding Share [%], by Agency – 2001, 2004 & 2009
Figure 13 Comparison in Weight of Pathogens Between BW Agents and CW Agents [mg]
Figure 14 Typical Point Detection Automated Architecture (With a Combined Trigger/Cue)
Figure 15 Airborne Bacterial Concentration Fluctuation in a Single Day
Figure 16 Cross-Section of Cascade Impactor: PIXE International Corporation
Figure 17 TSI's Model 3317 System with Concentrator, GPS Receiver & Wireless Data Radio
Figure 18 Biological Detection Technologies – 2010-2014
Figure 19 Flow Cytometry
Figure 20 Gas Chromatography
Figure 21 Polymerase Chain Reaction
Figure 22 RT–PCR
Figure 23 Principles of Real-Time PCR
Figure 24 DNA Microarrays – Principles of Operation
Figure 25 Schematic for Antibody Protein
Figure 26 Hand Held Detectors: Alexeter Guardian Reader System and Tetracore Test Strips
Figure 27 Roche Applied Science – Light CyclerTM Model 1.2
Figure 28 Bio-Detection Systems Sales by Generation [$M] – 2010-2014
Figure 29 Bio-Detection Systems Sales by Generation Share [%] – 2008, 2011 & 2014
Figure 30 Bio-Detection Systems Sales by Modality [$M] – 2010-2014
Figure 31 Bio-Detection Systems Sales by Modality Share [%] – 2008, 2011 & 2014
Figure 32 Bio-Detection Systems Quantity Sales by Generation [Units] – 2010-2014
Figure 33 Bio-Detection Systems Quantity Sales by Generation Share [%] – 2008, 2011 & 2014
Figure 34 Bio-Detection Systems Quantity Sales by Modality [Units] – 2010-2014
Figure 35 Bio-Detection Systems Quantity Sales by Modality Share [%] – 2008, 2011 & 2014
Figure 36 Bio-Detection Systems Installed Base by Generation [Units] – 2010-2014
Figure 37 Bio-Detection Systems Installed Base Share [%] by Generation – 2008, 2011 & 2014
Figure 38 Bio-Detection Systems Installed Base by Modality [Units] – 2008-2014
Figure 39 Bio-Detection Systems Installed Base by Modality Share [%] – 2008, 20011 & 2014
Figure 40 Outdoor Systems Standoff Detectors Sales by Generation [$M] – 2010-2014
Figure 41 Outdoor Standoff Detectors Systems Sales by Generation Share [%] – 2008, 2011 & 2014
Figure 42 Outdoor Standoff Detectors Systems Sales [Thousand of Units] – 2010-2014
Figure 43 Outdoor Standoff Detectors Systems – Sales Share [%] – 2008, 2011 & 2014
Figure 44 Outdoor Standoff-Detectors Systems Installed Base Units Share [Units] – 2010-2014
Figure 45 Outdoor Standoff Detectors Systems Installed Base Share [%] – 2008, 2011 & 2014
Figure 46 Indoor Standoff Detectors Systems Sales by Generation [$M] – 2010-2014
Figure 47 Indoor Standoff Detectors Systems Sales by Generation Share [%] – 2008, 2011 & 2014
Figure 48 Indoor Standoff Detectors Systems Unit Sales by Generation [Units] – 2010-2014
Figure 49 Indoor Standoff Detectors Systems Sales by Generation Share [%] – 2008, 2011 & 2014
Figure 50 Indoor Standoff-Detectors Systems Installed Base by Generation [Units] – 2010-2014
Figure 51 Indoor Standoff Detectors Systems Installed Bases by Generation Share [%] – 2008, 2011 & 2014
Figure 52 Point-Detectors Installed Base Systems Share by Modality [%] – 2008, 2011 & 2014
Figure 53 First Responder Hand-Held Detection Systems Sales [$M] by Generation – 2010-2014
Figure 54 First Responder Hand-Held Detection Systems Sales by Generation Share [%] – 2008, 2011 & 2014
Figure 55 First Responder Hand-Held Detection Systems Sales by Generation [Units] – 2010-2014
Figure 56 First Responder Hand-Held Detection Systems Sales by Generation Share [%] – 2008, 2011 & 2014
Figure 57 First Responder Hand-Held Detection Systems Installed Base by Generation [Units] – 2010-2014
Figure 58 First Responder Hand-Held Detection Systems Installed Base by Generation Share [%] – 2008, 2011 & 2014
Figure 59 First Responder Mobile Labs Sales by Generation [$M] – 2010-2014
Figure 60 First Responder Mobile Labs Sales by Generation Share [%] – 2008, 2011 & 2014
Figure 61 First Responder Mobile Labs Sales by Generation [Units] – 2010-2014
Figure 62 First Responder Mobile Labs Unit Sales by Generation Share [%] – 2008, 2011 & 2014
Figure 63 First Responder Mobile Labs Unit Installed Base by Generation Share [Units] – 2010-2014
Figure 64 First Responder Mobile Labs Installed Base by Generation Share [%] – 2008, 2011 & 2014
Figure 65 Bio-Detection Service & Upgrade Business Forecast by Modality [$M] – 2010-2014
Figure 66 Bio-Detection Service & Upgrade Business Forecast by Modality Share [%] – 2008, 2011 & 2014
Figure 67 Bio-Detection Service & Upgrade Business Forecast by Technology Generation [$M] – 2010-2014
Figure 68 Bio-Detection Service & Upgrade Business Forecast by Technology Generation [%] – 2008, 2011 & 2014
Figure 69 Factors Affecting Biological Detection Deployment and Technologies – 2010-2014
Figure 70 Bio-Detection Timeline
Figure 71 Civilians in China During the SARS Epidemic
Figure 72 A Typical Microfluidic Device
Figure 73 Bio-Defense R&D Federal Funding by Agency [$ Million] – 2010-2014
Figure 74 DHS Bio-Security R&D Budget Forecast [$ Million] – 2010-2014 (Without Bio-Shield Funding)
Figure 75 DOD Biosecurity R&D Budget Forecast [$ Million] – 2010-2014 (Without BioShield Funding)
Figure 76 DHHS Bio-security R&D Budget Forecast [$ Million] – 2010-2014
Figure 77 Other Agencies Biosecurity R&D Budget Forecast [$ Million] – 2010-2014
Figure 78 The Spraying of Anthrax from Aum Shinrikyo's Headquarters June 1993
Figure 79 Anthrax Spores and Disease
Figure 80 Cholera Bacteria
Figure 81 Pneumonic Plague – The Disease
Figure 82 Tularemia – The Disease
Figure 83 Smallpox Virus And Disease
Figure 84 Ebola Virus – Electron Microscopy Image
Figure 85 VEE – Venezuelan Equine Encephalitis Virus in the Olfactory Mucosa of a Mouse
Figure 86 Q Fever
Figure 87 Typhus Microbe – Electron Microscopy Image
Figure 88 Castor Plant And Structure For The Ricin Toxin
Figure 89  The Dinoflagellate Alexandrium Tamarense And Structure of Saxitoxin
More Info Questions about this report?
Contact us:

Sales: 1-571-527-1010
Analysts: 1-202-455-0966
Send us a message via the form below:

Fields marked with an * are required
FAQ Frequently Asked Questions

  • Q1: In what format are your reports?
    A1:
    Our reports are soft copy PDF files.
    We do not provide hard copies of our reports.
    Download a free PDF Reader.
  • Q2: How do I get the report I ordered?
    A2: Your report will be sent to you via email.
  • Q3: When will I get the report I ordered?
    A3: Upon placing your order/payment, notify our 24/7 hotline at: 1-202-455-0966 and the report will be emailed within a few moments, otherwise the mailing process will take up to 24 hours.
  • Q4: I am a small business. Can I get a discount?
    A4: Absolutely. If you qualify as a small business per the U.S. Business Administration guidelines (www.sba.gov) please contact us at maggie@hsrc.biz for the Small Business discount.
  • Q6: I would like to ask a question about a report, how can I contact you?
    A6: We welcome your questions, comments and suggestions.
    Please contact us at: info@hsrc.biz, our 24/7 hotline phone: 1-202-455-1968 or fax: 1-202-436-9484 and we will be happy to assist you.
  • Q7: How do I order a report?
    A7: You have several means to purchase a report:
      1. Via PayPal
        If you have a PayPal account, log in to PayPal from the link on the report's web page ("Order Info" tab) or directly on www.paypal.com.
        Press "Send Money", enter sales@hsrc.biz in the "To" field and the amount in the "Amount" field and continue filling out the PayPal form.
      2. Via Credit Card
        If you wish to pay using a credit card please send the credit card details: number, expiry date, Card Code (CVV) and name on card via fax to: 1-202-436-9484 or via 2 separate emails to maggie@hsrc.biz.
      3. Via Wire
        Wire funds to:
        Bank of America

        1140 Avenue of the Americas
        New York, NY 10036
        USA
        Account Name: Homeland Security Research Corp.
        Account Number: 483026774364.
        Routing Number: 021000322
        SWIFT: BOFAUS3N
      4. Via Check
        If you prefer to pay by check, please mail checks to:
        Homeland Security Research Corp.

        601 Pennsylvania Ave. NW Suite 900,
        South Building
        Washington D.C. 20004
  • Q8: What are the different license types?
    A8: License type definitions:
    1. Single User License (PDF): Authorizes one person to read and print out this report on any computer or mobile device.
      This person may not share the file with others.
    2. Departmental License (PDF): Authorizes up to five users within the same department and location to read and print the said report on any computer or mobile device.
      These five users may not share the file with others.
    3. Site License (PDF): Authorizes an unlimited number of users within the same business and/or agency location to read and print the said report on any computer or mobile device.
      These users may not share the file with others outside the enterprise location.
    4. Corporate Site License (PDF): Authorizes an unlimited number of users within the same enterprise worldwide to read and print out this report on any computer or mobile device.
      These users may not share the file with others outside the enterprise.